insitro aims to transform drug discovery using the power of machine learning and high-content data at scale. I support CEO Daphne Koller in defining company strategy, leading high-priority special projects, and ensuring efficient corporate operations

+ Completed over 50 engagements in a leading strategy consulting firm+ Managed teams of up to 10 consulting staff and presented directly to C-suite level clients+ Provided recommendations to clients to guide multimillion-dollar decisions about drug discovery priorities, clinical development, go-to-market strategy, and market access barriers+ Supported commercial due diligence processes on over $5 billion of transactions+ Experience across biopharma, health IT, and digital health in multiple therapeutic areas including neuroscience, oncology, and rare disease+ Conducted market research including over 500 expert interviews and over 10 surveys+ Developed financial models and other quantitative tools to inform clients' strategic decisions

+ Design and execute independent research project on PTEN-associated autism with macrocephaly.+ Generate mutant human embryonic stem cell lines via CRISPR-Cas9 and culture cerebral organoids.+ Collect data via immunofluorescence, confocal microscopy, and qPCR.+ Perform statistical analyses, create figures, and assemble results into reports and posters.

+ Isolated RNA from mouse and human choroid plexus tumor samples and analyzed gene expression with qRT-PCR.+ Imaged tissue samples using immunohistochemistry and confocal microscopy.

+ Literature review on circulatory system, sickle-cell disease, drug development, FDA approval, drug candidate (vepoloxamer), and main competitors.+ Compiled information into a 32,000 word original manuscript designed to orient new employees.